Finance

Lists
301207:SHE
Hualan Biological Vaccine Inc
CNÂ¥18.49
+6.14%
(+1.07) 1D
Sep 8, 3:04:46 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301207...
Open
CNÂ¥17.61
High
CNÂ¥18.50
Low
CNÂ¥17.43
Mkt. cap
10.30B
Avg. vol.
7.19M
Volume
13.98M
Dividend
7.57%
Quarterly dividend
CNÂ¥0.35
Ex-dividend date
Jun 15, 2026
P/E ratio
54.77
52-wk high
CNÂ¥27.88
52-wk low
CNÂ¥15.43
EPS
CNÂ¥0.34
Shares outstanding
601.03M
No. of employees
708
Open
CNÂ¥17.61
High
CNÂ¥18.50
Low
CNÂ¥17.43
Mkt. cap
10.30B
Avg. vol.
7.19M
Volume
13.98M
Dividend
7.57%
Quarterly dividend
CNÂ¥0.35
Ex-dividend date
Jun 15, 2026
P/E ratio
54.77
52-wk high
CNÂ¥27.88
52-wk low
CNÂ¥15.43
EPS
CNÂ¥0.34
Shares outstanding
601.03M
No. of employees
708
About Hualan Biological Vaccine Inc
CEO-
Employees708
FoundedNov 9, 2005
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
746.03M
396.52M
26.78M
17.61M
Cost of goods sold
182.87M
139.72M
7.79M
15.37M
Cost of revenue
182.87M
139.72M
7.79M
15.37M
Research and development expenses
29.46M
39.52M
20.78M
23.01M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
390.72M
140.54M
18.65M
26.00M
Operating expense
471.76M
215.90M
-595.40K
37.70M
Total operating expenses
654.63M
355.62M
7.19M
53.07M
Operating income
91.39M
40.90M
19.58M
-35.46M
Other non operating income
-67.28K
59.40K
-24.32K
16.73K
EBT including unusual items
126.43M
50.16M
40.47M
-5.02M
EBT excluding unusual items
108.71M
63.02M
34.60M
-19.37M
Income tax expense
14.91M
-453.17K
3.10M
-4.10M
Effective tax rate
11.80%
-0.90%
7.67%
81.62%
Other operating expenses
4.23M
3.16M
1.58M
-1.32M
Net income
111.51M
50.61M
37.37M
-922.55K
Net profit margin
14.95%
12.76%
139.55%
-5.24%
Earnings per share
-
-
-
-
Interest and investment income
17.35M
22.10M
15.04M
16.07M
Interest expense
-
-
-
-
Net interest expenses
17.35M
22.10M
15.04M
16.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
126.49M
76.17M
54.85M
-31.71K
Gain or loss from assets sale
-
204.77K
-
-
AI content may include mistakes. Learn more
Google apps